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Introduction: Coagulase-negative staphylococci are considered as microorganisms with little virulence and
usually as contaminants. In order to establish the role of Staphylococcus epidermidis as a pathogen in diabetic
foot osteomyelitis, in addition to the isolation of the sole bacterium from the bone it will be necessary to
demonstrate the histopathological changes caused by the infection.
Methods: A consecutive series of 222 diabetic patients with foot osteomyelitis treated surgically in the
Diabetic Foot Unit at La Paloma Hospital (Las Palmas de Gran Canaria, Canary Islands, Spain) between 1
October 2002 and 31 October 2008. From the entire series including 213 bone cultures with 241 isolated
organisms, we have analyzed only the 139 cases where Staphylococci were found. We analyzed several
variables between the two groups: Staphylococcus aureus versus Staphylococcus epidermidis.
Results: Of the 134 patients included in this study, Staphlylococcus epidermidis was found as the sole
bacterium isolated in 11 cases and accompanied by other bacteria in 12 cases. Staphlylococcus aureus was
found as the sole bacterium isolated in 72 cases and accompanied by other bacteria in 39 cases.
Histopathological changes were found in the cases of osteomyelitis where Staphylococcus epidermidis was
the sole bacterium isolated. Acute osteomyelitis was found to a lesser extent when Staphylococcus epidermidis
was the sole bacterium isolated but without significant differences with the cases where Staphylococcus aureus
was the sole bacterium isolated.
Conclusion: Staphylococcus epidermidis should be considered as a real pathogen, not only a contaminant, in
diabetic patients with foot osteomyelitis when the bacterium is isolated from the bone. No differences in the
outcomes of surgical treatment have been found with cases which Staphlylococcus aureus was isolated.
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O
steomyelitis is a challenging complication of
diabetic foot ulcers that may threaten the limb
of the patient. In nearly every series reported
in the literature, Staphylococcus aureus was the most
common pathogen cultured from bone samples in the feet
of diabetic patients, followed by Staphylococcus epider-
midis (1). Despite coagulase-negative staphylococci being
considered as microorganisms with little virulence (2) and
usually considered as contaminants in such conditions
(3), studies with microbiological examination of bone
samples have shown isolation rates of S. epidermidis
between 10 and 50% (47). Surprisingly, Senneville et al.
(4) found a higher rate of coagulase-negative staphylo-
cocci in bone biopsy samples than in swab samples
(25.6 vs. 4.6%; pB0.001). This finding may support the
idea that coagulase-negative staphylococci were true
pathogens in such cases, but the importance of this
finding is unclear because of the absence of histological
confirmation of osteomyelitis (4). Recently, a study has
been published that emphasizes the importance of S.
epidermidis as a pathogen in foot ulcers with protruding
bone, which suggests underlying osteomyelitis, and the
authors propose that S. epidermidis should be recognized
as a nosocomial pathogen (8). In order to establish the
role of S. epidermidis as a pathogen in diabetic foot
osteomyelitis, in addition to isolating the sole bacterium
from the bone, it will be necessary to demonstrate the
histopathological changes caused by the infection.
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with lower pathogenicity, it would be interesting to
compare the outcomes of the treatment with the cases
in which S. aureus is isolated. We are not aware of any
paper correlating the isolation of S. epidermidis from
bone biopsy with histopathological changes in diabetic
patients with foot osteomyelitis. The purpose of this
study is to analyze the bone histopathology when
S. epidermidis is the sole bacterium isolated from an
operative biopsy. In addition, we analyze the clinical
presentation and outcomes of the treatment, comparing
the cases of S. epidermidis with S. aureus.
Patients and methods
A consecutive series of 222 diabetic patients with foot
osteomyelitis were treated surgically in the Diabetic Foot
Unit at La Paloma Hospital (Las Palmas de Gran
Canaria, Canary Islands, Spain) between 1 October
2002 and 31 October 2008. From the entire series,
including 213 bone cultures with 241 isolated organisms,
we analyzed only 139 cases where staphylococci were
found. We excluded four cases without histopathological
confirmation of osteomyelitis, despite the isolation of the
bacteria from the bone sample. A further case where
S. aureus and S. epidermidis were found together was also
excluded. In total, the series studied included 134
patients. The diagnosis of infection was established on
the basis of the presence of purulent secretion or ]2
signs or symptoms of inflammation (9). The diagnosis of
osteomyelitis was made on the basis of a combination of
a probe-to-bone test (10) and a radiological study of the
foot. Limb ischemiawas diagnosed if any of the following
criteria were met: absence of both distal pulses, an ankle/
arm index below 0.9 or transcutaneous oxygen pressure
of B30 mmHg. Data about the patients were prospec-
tively collected using a computerized database, which
contains data on patient demographics, clinical evalua-
tion, presence of co-morbidities, prior amputations or
reulceration, previous antibiotic treatment and results of
laboratory tests. Blood cultures were not obtained. All
patients were operated on within the first 12 h after
admission to our hospital. All patients were given an
initial empirical antibiotic treatment with ampicillin/
sulbactam in the operating theatre during anesthetic
induction, except in cases of associated allergy. From 31
October 2007, we began to use amoxycillin/clavulanic
acid as the empirical preoperative antibiotic treatment. In
patients with a penicillin allergy, intravenous clindamycin
and ciprofloxacin were chosen as treatment. During
surgical intervention, samples were extracted from the
affected bone for analysis in microbiological and patho-
logical laboratories. No anaerobic cultures were per-
formed, as this is not the normal practice in our centre.
Surgical treatment was defined as conservative surgery if
only the infected bone and non-viable soft tissue, of
whatever size, were removedwithout amputating any part
of the foot; as minor amputations if they involved a
partial amputation of the foot that did not involve the
ankle joint, and as major amputations if located above
the ankle joint. Surgical treatment protocols were
the same irrespective of the bacteria isolated. This means
that re-operations were performed when local or general
sepsis was found, which could not be controlled using
antibiotics or minor in-bed debridements. Wounds were
left open to heal by second intention except in cases of
major amputations. Moist wound healing management
was always used, but it was varied according to the needs
of the patient. Once cultures and antibiograms were
available, the antibiotic administered was modified ac-
cording to the results. The length of postoperative
antibiotic treatment varied considerably, but, generally,
when the wound was totally occupied by granulation
tissue, antibiotic treatment was discontinued. Histo-
pathological findings in bone specimens were defined as
acute osteomyelitis when necrosis, destroyed bone, and
infiltration by polymorphonuclear granulocytes at corti-
cal sites and inside the bone marrow were present.
Congestion or thrombosis of the medullary or periosteal
small vessels were also frequently found. Osteomyelitis
was defined as chronic when there was destroyed bone
and infiltration by lymphocytes, histiocytes, and/or plas-
matic cells at cortical sites and inside the bone marrow.
The histopathological changes were defined as acute
exacerbation of chronic osteomyelitis when there was a
background of chronic osteomyelitis with infiltration of
polymorphonuclear granulocytes. All three forms of
osteomyelitis exhibited areas of fibrosis in variable forms
and medullar edema (7). Healing was defined as complete
epithelization of the ulcer and/or the surgical wound
resulting from the removal of bone. Patients were
followed until healing. Postoperative death is defined as
that occurring within 30 days of surgery.
The study was conducted in accordance with the
Declaration of Helsinki as revised in 2000. This retro-
spective study did not require approval by an ethics
committee since the procedures did not alter or exceed
the scope of our standard medical care. All patients gave
written informed consent for surgery, for photographs
taken of their wounds, to be included in our computer
databaseandfortheir(anonymized) casestobe published.
Statistical analysis
We analyzed several variables between the two groups:
S. aureus vs. S. epidermidis. Qualitative variables were
analyzed by Fisher’s exact test and non-normally distrib-
uted quantitative variables by using the non-parametric
MannWhitney U test. Differences were considered sta-
tistically significant when p-values were less than 0.05.
Statistical analysis was performed using Statplus statis-
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Canada).
Results
From the 134 patients included in this study, S.
epidermidis was found as the sole bacterium isolated in
11 cases and accompanied by other bacteria in 12 cases.
S. aureus was found as the sole bacterium isolated in 72
cases and accompanied by other bacteria in 39 cases.
Methicillin-resistant Staphylococcus aureus [MRSA]
was isolated in 39 out of these 111 cases (35.1%).
S. epidermidis was vancomycin-resistant on two occa-
sions (8.6%). The bacteria that were found together with
staphylococci are shown in Table 1. Histopathological
changes were found in the cases of osteomyelitis where S.
epidermidis was the sole bacterium isolated. No statisti-
cally significant differences in the duration of the ulcer
or previous antibiotic treatment were found. Acute
osteomyelitis was found to a lesser extent when S.
epidermidis was the sole bacterium isolated, but without
significant differences with the cases where S. aureus was
the sole bacterium isolated. Clinical presentation and
outcomes between the two groups are summarized in
Table 2.
Discussion
S. epidermidis, a non-pathogenic member of common cut-
aneous microbial flora, expresses few virulence factors
under normal conditions (11). Coagulase-negative
Staphylococcus spp., such as S. Epidermidis, are respon-
sible for the majority of chronic osteomyelitis associated
with orthopedic implants (12). S. epidermidis has been
regarded as a contaminant in a series of osteomyelitis (3),
(13), but the isolation of this bacterium is very frequent in
a series using bone biopsies. Authors show 9% (14),
10.7% (7), 11% (5), and 50% (6) of S. epidermidis in their
series. Other authors found 25.6% (4) and 40% (15) of
coagulase-negative staphylococci in bone biopsy samples.
Lavery et al. (5) state that a possible explanation for the
difference between their series and Newman’s series (6)
may be the fact that intraoperative bone cultures used by
the Lavery team may be less prone to contamination than
the percutaneous technique. The technique chosen for
sampling (needle puncture or transcutaneous bone
biopsy) may also have some influence on the isolation
of coagulase-negative staphylococci: 7.1% in bone biopsy
specimens and 19.5% in needle puncture specimens (16).
Although histopathology was performed in some of these
studies, authors did not show the histopathological find-
ings in the cases where coagulase-negative staphylococci
were isolated. All the patients in our series were operated
on because the clinical signs and exploration suggested
the presence of osteomyelitis. Samples from subsequent
bone biopsies where S. epidermidis was isolated, showed
histopathological changes that confirmed the diagnosis.
In this way, we are able to propose that S. epidermidis
behaved as a true pathogen agent. This proposition
cannot be definitively proved since no anaerobic cultures
were performed. Anaerobic bacteria could also have been
responsible for the histopathological changes in the cases
where S. epidermidis was the sole bacteria isolated.
Nonetheless, the role of anaerobic bacteria in diabetic
foot osteomyelitis is not well understood because bone
biopsy-based osteomyelitis studies only show 3% (14), 4%
(6), 4.8% (4), 11.9% (16), and 14% (5) of anaerobes.
We think, as do others, that the mixed aerobic-anaerobic
infections commonly identified in soft tissue infections in
diabetics are not characteristic of bone infections of
the foot in diabetic patients (5). For these reasons, we
believe that anaerobic bacteria played little part, if any,
in the histopathological changes when S. epidermidis was
the sole bacterium isolated and these changes were caused
by S. epidermidis itself. Our postoperative management
is to leave the surgical wounds open for healing by
secondary intention and this is a hostile environment for
the growth of anaerobic bacteria. Furthermore, we think,
like others (17), that anaerobes were easily eliminated by
aggressive debridement and making anaerobic cultures
could not therefore contribute to optimizing the treat-
ment of these patients (18).
Recently, it has been reported that diabetic patients
with ischemic foot ulcers differ from neuropathic foot
ulcer patients, having a higher frequency of S. epidermidis
skin colonization and ulcer infection (8). The authors of
this prospective study found significant differences in the
rate of isolation of S. epidermidis between neuropathic
and ischemic ulcers when the toe web surface was
swabbed and when they performed curettage of the
ulcers. They suggest a predilection of S. epidermidis for
ischemic tissue. However, there was no statistically
significant difference when the sample was obtained by
biopsy: 12.5% in neuropathic ulcers vs. 10% in ischemic
ulcers. This may mean that S. epidermidis colonized the
Table 1. Bacteria isolated from bone biopsy together with
staphylococci
Staphylococcus
aureus (n39)
Staphylococcus
epidermidis (n12)
Escherichia coli 10 (25.6%) 0
Enterobacter species 8 (20.5%) 3 (25%)
Pseudomonas species 8 (20.5%) 2 (16.6%)
Proteus species 4 (10.2%) 5 (41.6%)
Acinetobacter species 3 (7.7%) 0
Citrobacter species 2 (5.1%) 1 (8.3%)
Klebsiella species 1 (2.5%) 1 (8.3%)
Serratia odorifera 1 (2.5%) 0
Shigella species 1 (2.5%) 0
Streptococcus viridians 1 (2.5%) 0
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factors other than ischemia led to infection. The differ-
ence between infection and colonization in diabetic foot
ulcers defined in terms of microbiological factors is still
an unresolved issue. We have not found any significant
differences in the presence of ischemia between the
groups. No differences in clinical presentation, metabolic
control or ulcer duration have been found in our study.
Authors investigated the hypothesis that like S. aureus,
S. epidermidis can also invade bone cells evading
antimicrobial therapy and may therefore explain the
difficulties in treating such infections (19) They found
that S. epidermidis was capable of invading bone cells, but
that there were significant strain-dependent differences
in this ability (19). The virulence and pathogenicity of
strains of S. epidermidis may be related more to genetic
factors in the bacteria than to local conditions in the
hosts. We speculate that the identification of such strains
in bone biopsies may help in the choice between surgical
treatment and antibiotic treatment. However, this may be
as difficult here as it has been shown in other clinical
settings (20).
We have not found significant differences in the out-
comes of treatment in the cases where S. epidermidis was
found compared with S. aureus. This finding may be
surprising, but we believe that surgical treatment deter-
mines the outcomes of the treatment irrespective of the
bacteria present. We have previously reported that MRSA
bone infections treated by early and aggressive surgical
treatment are not associated with worse prognosis (21).
Another limitation of this study is the small number of
caseswhereS.epidermidiswasisolated. This is a determin-
ing factor that limits the statistical conclusions. However,
the total number of cases where staphylococci were
isolated is large enough to contribute to the knowledge
of the role of S. epidermidis in diabetic foot osteomyelitis.
In conclusion, we have presented a series of cases in
which S. epidermidis was isolated from a bone biopsy
Table 2. Clinical presentation and outcomes between Staphylococcus epidermidis and Staphylococcus aureus
Staphylococcus epidermidis
as sole isolated (n11)
Staphylococcus aureus
as sole isolated (n72) P
Age (years)
a 68 (8) 65.5 (16) 0.34
Years since diagnosis of diabetes
a 16 (18) 19 (10) 0.87
Glycated hemoglobin, proportion of total hemoglobin
a 0.086 (0.029) 0.082 (0.026) 0.29
Previous ulcer, n (%) 7 (63.6) 45 (62.5) 1
Previous amputation, n (%) 4 (36.4) 37 (51.4) 0.52
Ulcer as point of entry of infection, n (%) 11 (100) 65 (90.3) 0.58
Ulcer duration in days
a 60 (120) 30 (106) 0.06
Previous antibiotherapy, n (%) 7 (63.6) 60 (83.3) 0.21
Fetid smelling, n (%) 4 (36.4) 22 (30.6) 0.73
Necrosis, n (%) 3 (27.3) 22 (30.6) 0.56
Exposed bone, n (%) 3 (27.3) 17 (23.6) 0.72
Probing to bone test positive, n (%) 9 (81.8) 66 (91.7) 0.28
Positive signs in X-ray, n (%) 8 (72.7) 61 (84.7) 0.38
Ischemia, n (%) 8 (72.7) 38 (52.8) 0.33
White blood cell count, 10
9/l
a 7,380 (6,500) 9,400 (3,838) 0.3
Leukocytosis, n (%) 4 (36.4) 18 (25) 0.47
Erythrocyte sedimentation rate (mm/h)
a 72.5 (81) 78 (50) 0.55
Alkaline phosphatase (U/l)
a 219 (308) 146 (186) 0.15
Conservative surgery, n (%) 7 (63.6) 42 (58.3) 1
Minor amputations, n (%) 4 (36.4) 29 (40.3) 1
Major amputations, n (%) 0 (0) 1 (1.4) 1
Number of surgical procedures, n (%) 1 (0) 1 (1) 0.43
Acute osteomyelitis, n (%) 3 (27.3) 39 (54.2) 0.11
Chronic osteomyelitis, n (%) 4 (36.4) 15 (20.8) 0.26
Acute exacerbation of chronic osteomyelitis, n (%) 4 (36.4) 18 (25) 0.47
Perioperative death, n (%) 1 (9.1) 1 (1.4) 0.24
Hospital stay (days)
a 15 (16) 16 (39) 0.48
Time to healing (days)
a 75 (69) 102 (103) 0.06
aValues are expressed as median (interquartile range).
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S. epidermidis should be considered as a real pathogen,
not only as a contaminant, in diabetic patients with foot
osteomyelitis when the bacterium has been isolated from
the bone. No differences in the outcomes of surgical
treatment have been found with cases in which S. aureus
was isolated.
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